+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gene Cloning Services Market by Service Type, Application, End User, Technology Used, Source - Global Forecast to 2030- Product Image
Gene Cloning Services Market by Service Type, Application, End User, Technology Used, Source - Global Forecast to 2030- Product Image
Sale

Gene Cloning Services Market by Service Type, Application, End User, Technology Used, Source - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925088
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The gene cloning services market is evolving rapidly as technological advancements, automation, and emerging applications reshape priorities for innovation-driven organizations. Senior leaders require actionable insights to ensure strategic decisions drive research and product development forward.

Market Snapshot: Gene Cloning Services Market

The Gene Cloning Services Market grew from USD 2.63 billion in 2024 to USD 2.95 billion in 2025. It isexpected to continue growing at a CAGR of 12.22%, reaching USD 5.25 billion by 2030. This growth is driven by increased demand for cutting-edge gene synthesis, regulatory shifts, and expanding application of gene cloning across medical, agricultural, and industrial sectors. Providers are responding to heightened expectations for speed, scalability, and technological sophistication, all while navigating global supply chain and regulatory complexities.

Scope & Segmentation

  • Service Types: Gene synthesis, including codon optimization, de novo synthesis, fragment assembly; mutagenesis, such as random and site-directed mutagenesis; subcloning; vector construction, involving Gibson Assembly, Golden Gate Assembly, recombinant cloning, and restriction enzyme cloning.
  • Applications: Agricultural biotechnology, drug discovery and development (functional analysis, lead optimization, target validation), medical diagnostics, and research.
  • End Users: Academic and research institutes, contract research organizations, hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies (large pharma, small and medium biotech firms).
  • Technologies Used: Gibson Assembly, Golden Gate Assembly, recombinant cloning (Gateway, In-Fusion), restriction enzyme cloning, TA cloning.
  • Source Models: In-house (industry facilities, university core labs) and outsourced (contract research organizations, third-party service providers).
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Gulf states, and more), Asia-Pacific (including China, India, Japan, Australia, Southeast Asia).
  • Company Coverage: Key profiles include Thermo Fisher Scientific Inc., Merck KGaA, QIAGEN N.V., Agilent Technologies, Inc., Eurofins Scientific SE, Bio-Rad Laboratories, Inc., Twist Bioscience Corporation, GenScript Biotech Corporation, Azenta, Inc., BGI Genomics Co., Ltd.

Key Takeaways for Senior Decision-Makers

  • Precision genome engineering and AI-integrated workflows are setting new standards for efficiency and reliability in gene cloning services.
  • Automation platforms are streamlining de novo synthesis and codon optimization, while minimizing manual intervention and variability.
  • Cloud-enabled data management and digital lab integration support real-time collaboration among distributed research teams, increasing project turnaround consistency.
  • Bespoke cloning services and flexible operating models are gaining traction, especially among organizations developing personalized or high-complexity therapeutics.
  • The trend toward outsourcing, particularly to contract research organizations, reflects the need for specialized expertise and global reach amid evolving regulatory environments.
  • Sustainability initiatives—such as minimizing reagent waste and implementing green protocols—are increasingly influencing provider selection and partnership strategies.

Tariff Impact: Navigating U.S. Policy Changes

The introduction of new U.S. tariffs on imported plasmids, enzymes, and specialized consumables is increasing cost pressure throughout the gene cloning supply chain. Service providers are reevaluating supplier relationships, exploring domestic sourcing, and renegotiating contracts to offset these impacts. Adaptability in procurement and supply network localization has become a priority, with some vendors investing directly in in-house reagent production or forming regional alliances to support continuity and cost management. Strategic operational shifts foster competitive resilience in anticipation of future policy changes.

Methodology & Data Sources

This report’s findings derive from a rigorous methodology that includes extensive secondary research—peer-reviewed publications, patent analyses, and regulatory documents—alongside primary interviews with senior executives, laboratory leaders, and industry association representatives. The use of data triangulation ensures both quantitative accuracy and qualitative relevance, with subject matter experts validating approach and conclusions.

Why This Report Matters

  • Enables data-driven decisions by mapping service types, technological innovations, regulatory trends, and competitive strategies critical to business outcomes in gene cloning.
  • Identifies region-specific growth opportunities, helping organizations prioritize investments and partnerships for market expansion or operational risk mitigation.
  • Equips executive teams with actionable recommendations on automation, outsourcing, sustainability, and supply chain diversification to remain agile in a dynamic landscape.

Conclusion

This analysis clarifies the forces shaping the gene cloning services market, from automation and AI to regulatory adaptation. Stakeholders leveraging these insights can enhance strategic positioning and foster innovation across life sciences and related industries.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gene Cloning Services Market, by Service Type
8.1. Introduction
8.2. Gene Synthesis
8.2.1. Codon Optimization
8.2.2. De Novo Synthesis
8.2.3. Fragment Assembly
8.3. Mutagenesis
8.3.1. Random Mutagenesis
8.3.2. Site Directed Mutagenesis
8.4. Subcloning
8.5. Vector Construction
8.5.1. Gibson Assembly
8.5.2. Golden Gate Assembly
8.5.3. Recombinant Cloning
8.5.4. Restriction Enzyme Cloning
9. Gene Cloning Services Market, by Application
9.1. Introduction
9.2. Agricultural Biotechnology
9.3. Drug Discovery and Development
9.3.1. Functional Analysis
9.3.2. Lead Optimization
9.3.3. Target Validation
9.4. Medical Diagnostics
9.5. Research
10. Gene Cloning Services Market, by End User
10.1. Introduction
10.2. Academic and Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals and Diagnostic Laboratories
10.5. Pharmaceutical and Biotechnology Companies
10.5.1. Large Pharma
10.5.2. Small and Medium Biotech Firms
11. Gene Cloning Services Market, by Technology Used
11.1. Introduction
11.2. Gibson Assembly
11.3. Golden Gate Assembly
11.4. Recombinant Cloning
11.4.1. Gateway
11.4.2. in-Fusion
11.5. Restriction Enzyme Cloning
11.6. TA Cloning
12. Gene Cloning Services Market, by Source
12.1. Introduction
12.2. in-House
12.2.1. Industry Facilities
12.2.2. University Core Labs
12.3. Outsourced
12.3.1. Contract Research Organizations
12.3.2. Third-Party Service Providers
13. Americas Gene Cloning Services Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Gene Cloning Services Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Gene Cloning Services Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. QIAGEN N.V.
16.3.4. Agilent Technologies, Inc.
16.3.5. Eurofins Scientific SE
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. Twist Bioscience Corporation
16.3.8. GenScript Biotech Corporation
16.3.9. Azenta, Inc.
16.3.10. BGI Genomics Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GENE CLONING SERVICES MARKET MULTI-CURRENCY
FIGURE 2. GENE CLONING SERVICES MARKET MULTI-LANGUAGE
FIGURE 3. GENE CLONING SERVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GENE CLONING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GENE CLONING SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. GENE CLONING SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GENE CLONING SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENE CLONING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY CODON OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY DE NOVO SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY FRAGMENT ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY RANDOM MUTAGENESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SUBCLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GIBSON ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GOLDEN GATE ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY RESTRICTION ENZYME CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY FUNCTIONAL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SMALL AND MEDIUM BIOTECH FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GIBSON ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GOLDEN GATE ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GATEWAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY IN-FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY RESTRICTION ENZYME CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY TA CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY INDUSTRY FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY UNIVERSITY CORE LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY THIRD-PARTY SERVICE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 86. CANADA GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 87. CANADA GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 88. CANADA GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 89. CANADA GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 90. CANADA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. CANADA GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 92. CANADA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. CANADA GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 94. CANADA GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 95. CANADA GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 96. CANADA GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 97. CANADA GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 98. CANADA GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 99. MEXICO GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 100. MEXICO GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 102. MEXICO GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 103. MEXICO GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. MEXICO GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 105. MEXICO GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. MEXICO GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 107. MEXICO GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 108. MEXICO GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 109. MEXICO GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 110. MEXICO GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 111. MEXICO GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 165. GERMANY GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 166. GERMANY GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 167. GERMANY GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 168. GERMANY GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 169. GERMANY GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. GERMANY GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 171. GERMANY GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. GERMANY GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 173. GERMANY GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 174. GERMANY GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 175. GERMANY GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 176. GERMANY GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 177. GERMANY GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 178. FRANCE GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 179. FRANCE GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 180. FRANCE GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 181. FRANCE GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 182. FRANCE GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. FRANCE GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 184. FRANCE GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. FRANCE GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 186. FRANCE GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 187. FRANCE GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 188. FRANCE GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 189. FRANCE GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 190. FRANCE GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 204. ITALY GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 205. ITALY GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 206. ITALY GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 207. ITALY GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 208. ITALY GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. ITALY GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 210. ITALY GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. ITALY GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 212. ITALY GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 213. ITALY GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 214. ITALY GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 215. ITALY GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 216. ITALY GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 217. SPAIN GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 218. SPAIN GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 219. SPAIN GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 220. SPAIN GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 221. SPAIN GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. SPAIN GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 223. SPAIN GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. SPAIN GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 225. SPAIN GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 226. SPAIN GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 227. SPAIN GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 228. SPAIN GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 229. SPAIN GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 254. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 266. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 267. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 269. DENMARK GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 270. DENMARK GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 271. DENMARK GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 272. DENMARK GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 273. DENMARK GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. DENMARK GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 275. DENMARK GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. DENMARK GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 277. DENMARK GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 278. DENMARK GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 279. DENMARK GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 280. DENMARK GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 281. DENMARK GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 295. QATAR GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 296. QATAR GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 297. QATAR GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 298. QATAR GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 299. QATAR GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. QATAR GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 301. QATAR GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. QATAR GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 303. QATAR GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 304. QATAR GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 305. QATAR GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 306. QATAR GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 307. QATAR GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 308. FINLAND GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 309. FINLAND GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 310. FINLAND GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 311. FINLAND GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 312. FINLAND GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. FINLAND GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 314. FINLAND GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. FINLAND GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 316. FINLAND GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 317. FINLAND GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 318. FINLAND GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 319. FINLAND GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 320. FINLAND GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 321. SWEDEN GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Gene Cloning Services market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Eurofins Scientific SE
  • Bio-Rad Laboratories, Inc.
  • Twist Bioscience Corporation
  • GenScript Biotech Corporation
  • Azenta, Inc.
  • BGI Genomics Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.95 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.25 Billion
Compound Annual Growth Rate12.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

DNA And Gene Cloning Services Market Size, Share & Trends Analysis Report By Service (Gene Synthesis, Custom Cloning), By Application (DNA Sequencing, Mutagenesis), By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

DNA And Gene Cloning Services Market Size, Share & Trends Analysis Report By Service (Gene Synthesis, Custom Cloning), By Application (DNA Sequencing, Mutagenesis), By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
DNA and Gene Cloning Services - Global Strategic Business Report - Product Image

DNA and Gene Cloning Services - Global Strategic Business Report

  • Report
  • 178 Pages
  • Global
From
DNA And Gene Cloning Services Global Market Report 2025 - Product Image

DNA And Gene Cloning Services Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Cloning and Mutagenesis Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Cloning and Mutagenesis Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Cloning & Mutagenesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Cloning & Mutagenesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From

About the Gene Cloning Market

Gene Cloning is a process used in genomics to create copies of genes or other DNA fragments. It is used to produce large amounts of a particular gene or gene product for research or therapeutic purposes. The gene cloning market is driven by the increasing demand for gene-based therapies, the growing prevalence of genetic diseases, and the increasing use of gene-based diagnostics. The market is also driven by the increasing investments in genomics research and the increasing demand for personalized medicine. The gene cloning market is segmented into products, services, applications, and end-users. The products segment includes reagents, kits, enzymes, and other consumables. The services segment includes contract research services, sequencing services, and bioinformatics services. The applications segment includes drug discovery, diagnostics, and research. The end-users segment includes pharmaceutical and biotechnology companies, academic and research institutes, and hospitals and diagnostic centers. Some of the major companies in the gene cloning market are Thermo Fisher Scientific, Agilent Technologies, Illumina, Inc., Merck KGaA, QIAGEN, Bio-Rad Laboratories, Inc., New England Biolabs, Inc., Takara Bio, Inc., and Lonza Group. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.